Daikenchuto (TU-100)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Daikenchuto (TU-100), covering 2015-06-11 to 2017-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome [Phase 2]